S&P 500   3,960.27 (+0.67%)
DOW   33,719.47 (+0.36%)
QQQ   283.23 (+0.96%)
AAPL   141.98 (+0.74%)
MSFT   246.69 (+0.95%)
META   115.51 (+1.39%)
GOOGL   94.03 (-0.96%)
AMZN   89.79 (+1.50%)
TSLA   172.39 (-0.95%)
NVDA   169.16 (+4.94%)
NIO   13.32 (+5.88%)
BABA   94.02 (+6.44%)
AMD   69.77 (-0.53%)
T   19.12 (-0.93%)
MU   55.14 (+2.45%)
CGC   2.99 (-7.72%)
F   13.11 (+0.08%)
GE   83.24 (-2.07%)
DIS   92.34 (+0.21%)
AMC   6.14 (+1.49%)
PYPL   74.22 (-0.27%)
PFE   51.68 (+2.87%)
NFLX   308.23 (-0.06%)
S&P 500   3,960.27 (+0.67%)
DOW   33,719.47 (+0.36%)
QQQ   283.23 (+0.96%)
AAPL   141.98 (+0.74%)
MSFT   246.69 (+0.95%)
META   115.51 (+1.39%)
GOOGL   94.03 (-0.96%)
AMZN   89.79 (+1.50%)
TSLA   172.39 (-0.95%)
NVDA   169.16 (+4.94%)
NIO   13.32 (+5.88%)
BABA   94.02 (+6.44%)
AMD   69.77 (-0.53%)
T   19.12 (-0.93%)
MU   55.14 (+2.45%)
CGC   2.99 (-7.72%)
F   13.11 (+0.08%)
GE   83.24 (-2.07%)
DIS   92.34 (+0.21%)
AMC   6.14 (+1.49%)
PYPL   74.22 (-0.27%)
PFE   51.68 (+2.87%)
NFLX   308.23 (-0.06%)
S&P 500   3,960.27 (+0.67%)
DOW   33,719.47 (+0.36%)
QQQ   283.23 (+0.96%)
AAPL   141.98 (+0.74%)
MSFT   246.69 (+0.95%)
META   115.51 (+1.39%)
GOOGL   94.03 (-0.96%)
AMZN   89.79 (+1.50%)
TSLA   172.39 (-0.95%)
NVDA   169.16 (+4.94%)
NIO   13.32 (+5.88%)
BABA   94.02 (+6.44%)
AMD   69.77 (-0.53%)
T   19.12 (-0.93%)
MU   55.14 (+2.45%)
CGC   2.99 (-7.72%)
F   13.11 (+0.08%)
GE   83.24 (-2.07%)
DIS   92.34 (+0.21%)
AMC   6.14 (+1.49%)
PYPL   74.22 (-0.27%)
PFE   51.68 (+2.87%)
NFLX   308.23 (-0.06%)
S&P 500   3,960.27 (+0.67%)
DOW   33,719.47 (+0.36%)
QQQ   283.23 (+0.96%)
AAPL   141.98 (+0.74%)
MSFT   246.69 (+0.95%)
META   115.51 (+1.39%)
GOOGL   94.03 (-0.96%)
AMZN   89.79 (+1.50%)
TSLA   172.39 (-0.95%)
NVDA   169.16 (+4.94%)
NIO   13.32 (+5.88%)
BABA   94.02 (+6.44%)
AMD   69.77 (-0.53%)
T   19.12 (-0.93%)
MU   55.14 (+2.45%)
CGC   2.99 (-7.72%)
F   13.11 (+0.08%)
GE   83.24 (-2.07%)
DIS   92.34 (+0.21%)
AMC   6.14 (+1.49%)
PYPL   74.22 (-0.27%)
PFE   51.68 (+2.87%)
NFLX   308.23 (-0.06%)
NYSE:CI

Cigna - CI Price Target & Analyst Ratings

$333.65
+1.46 (+0.44%)
(As of 12/8/2022 02:47 PM ET)
Add
Compare
Today's Range
$332.08
$335.65
50-Day Range
$277.47
$332.19
52-Week Range
$206.44
$332.90
Volume
39,164 shs
Average Volume
1.95 million shs
Market Capitalization
$102.01 billion
P/E Ratio
15.93
Dividend Yield
1.36%
Price Target
$329.32

Cigna Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 21 Analyst Ratings

Consensus Analyst Price Target

$329.32
-1.30% Downside
High Prediction$385.00
Average Prediction$329.32
Low Prediction$270.00
TypeCurrent
12/8/21 to 12/8/22
1 Month Ago
11/8/21 to 11/8/22
3 Months Ago
9/9/21 to 9/9/22
1 Year Ago
12/8/20 to 12/8/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
13 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
13 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$329.32$326.64$308.82$266.00
Predicted Upside-1.30% Downside15.96% Upside14.88% Upside22.35% Upside
Get Cigna Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.


CI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cigna Stock vs. The Competition

TypeCignaFinance CompaniesS&P 500
Consensus Rating Score
2.62
2.45
2.48
Consensus RatingModerate BuyHoldHold
Predicted Upside-0.86% Downside62.74% Upside15.57% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
887
72.53%
Underperform Votes
336
27.47%
Avg. Outperform Votes
149
62.08%
Avg. Underperform Votes
91
37.92%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/23/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ricky Goldwasser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight$318.00 ➝ $347.00+8.66%
11/21/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Outperform$370.00+15.91%
11/10/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$330.00 ➝ $360.00+11.59%
11/8/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$319.00 ➝ $370.00+14.07%
11/8/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$305.00 ➝ $335.00+3.28%
11/7/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform$294.00 ➝ $344.00+6.79%
11/7/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$329.00 ➝ $385.00+19.52%
11/7/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$329.00 ➝ $368.00+14.24%
11/4/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$320.00 ➝ $360.00+11.03%
8/9/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$273.00 ➝ $311.00+8.48%
8/8/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$310.00 ➝ $330.00+16.69%
7/14/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$330.00 ➝ $271.00-1.00%
7/14/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$310.00 ➝ $330.00+20.55%
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$270.00+8.87%
6/9/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$236.00 ➝ $284.00+8.90%
5/27/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMkt Perform$258.00 ➝ $301.00+11.95%
5/26/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
upgrades, downgrades
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$265.00 ➝ $300.00+12.89%
5/23/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$275.00 ➝ $310.00+19.47%
5/16/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lisa Gill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$248.00 ➝ $304.00+17.29%
5/9/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$300.00 ➝ $320.00+19.90%
4/20/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$265.00 ➝ $290.00+11.10%
11/17/2021Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
8/6/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$308.00 ➝ $267.00+29.48%
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$234.00 ➝ $236.00+7.18%
4/13/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$280.00 ➝ $240.00+31.99%
2/7/2020Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Newshel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$230.00+10.09%
2/6/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight$245.00 ➝ $255.00+20.70%
(Data available from 12/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CI Price Target - Frequently Asked Questions

What is Cigna's consensus rating and price target?

According to the issued ratings of 21 analysts in the last year, the consensus rating for Cigna stock is Moderate Buy based on the current 8 hold ratings and 13 buy ratings for CI. The average twelve-month price prediction for Cigna is $329.32 with a high price target of $385.00 and a low price target of $270.00. Learn more on CI's analyst rating history.

Do Wall Street analysts like Cigna more than its competitors?

Analysts like Cigna more than other Finance companies. The consensus rating for Cigna is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how CI compares to other companies.

Do MarketBeat users like Cigna more than its competitors?

MarketBeat users like Cigna more than other Finance companies. 72.53% of MarketBeat users gave Cigna an outperform vote while finance companies recieve an average of 62.08% outperform votes by MarketBeat users.

Is Cigna being downgraded by Wall Street analysts?

Over the previous 90 days, Cigna's stock had 1 downgrade by analysts.

Does Cigna's stock price have much upside?

According to analysts, Cigna's stock has a predicted upside of 14.62% based on their 12-month price targets.

What analysts cover Cigna?

Stock Ratings Reports and Tools

This page (NYSE:CI) was last updated on 12/8/2022 by MarketBeat.com Staff